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Abstract 
Background:  To determine association between 
placenta previa and pre-eclampsia in pregnant 
women presenting to a tertiary care hospital. 
Methods: In this prospective study 187 pregnant 
women with placenta previa and 187 pregnant, total 
374, women without placenta previa were enrolled. 
Ultrasonography examination was performed on all 
patients to ascertain the attachment of placenta on 
uterine wall. All patients were followed every fourth 
week till 38th weeks. Pre-eclampsia was labelled if 
mean of three readings of blood pressure was more 
than 139/89 in a pregnant woman with history of 
normal blood pressure before pregnancy and 
proteinuria on urine laboratory examination. 
Results: Mean age  was 27.23 ± 3.633 and ranged 
from 21 to 43 years. Primipara were 45.7% and 54.3% 
were multipara. Eight patients (2.1%) were having 
pre-eclampsia. All patients belonged to non- 
placenta previa group. Relative risk came out 1.045 
ranging from1.014 to 1.077 at 95% confidence 
interval. There was no effect of age and parity on the 
association. 
Conclusion: There is a protective association 
between placenta previa and pre-eclampsia in 
pregnant women. 
Key Words: Placenta previa, Pre-eclampsia, 
Pregnancy induced hypertension, Parity 
 
Introduction 
Hypertension complicates up to 10% of all pregnancies 
and is associated with increased risk of adverse fetal, 
neonatal and maternal outcomes, including preterm 
birth, intrauterine growth restriction, perinatal death, 
acute renal or hepatic failure, antepartum hemorrhage, 
postpartum hemorrhage and maternal death.1, 2 
Pregnancy hypertension has its onset from 20 weeks of 
gestation and ranges from hypertension alone through 
proteinuria and multi-organ dysfunction to seizures.3 
Between 2011 and 2013, pregnancy-induced 
hypertension caused 7.4% of maternal deaths in the 
United States.4 Pre-eclampsia may be superimposed 
on pre-existing chronic hypertension. Although pre-
eclampsia represents the severe end of the spectrum, 
women with any form of pregnancy hypertension are 
at increased risk of adverse outcomes.5, 6 In a study 
PIH have demonstrated an increased risk for 
intrauterine growth retardation.7 
Placenta previa is associated with major pregnancy 
complications and is thought to be becoming more 
common.8 It is also associated with PIH.9 Some studies 
reported the protective effects, other studies did show 
any associations, slightly increase in the incidence and 
significantly elevated incidence of spectrum of 
hypertension ranging from PIH to eclampsia in 
women with placenta previa.9, 10 Placenta previa was a 
significant protective factor of pre-eclampsia showing 
negative association.6, 9 In another Japanese study, 
Preeclampsia was observed in 0 and 4.1% of women 
with and without placenta previa, respectively.11, 12 But 
the impact of these changes is largely unknown.5 
Validation of the above mentioned results in our local 
population i.e. reduced frequency of pre-eclampsia in 
patients with placenta previa may help us make 
certain management decisions. Evidence based 
counselling will be possible for patients with previous 
abortions and miscarriages secondary to pre-eclampsia 
as there would be no risk if they have placenta previa.  
 
Patients and Methods 
This prospective cohort study was conducted in 
Department of Gynaecology, Sir Ganga Ram Hospital, 
Lahore from October 2014 toApril 2015.Using 95% 
confidence interval and 80% power of study, taking 
frequency of pre-eclampsia 0% and 4.1% (7) in groups 
with and without placenta previa respectively, 
estimated sample size is 374 i.e. 187 in each group. 
Pregnant women of age 18-45 years at gestational age 
<24weeks (determined by last menstrual period) were 
included. One group women were with placenta 
previa determined by ultrasonography while second 
group women were without placenta previa. Females 
with history of chronic hypertension, diabetes (HbA1C 
level > 7%), severe anaemia (haemoglobin level, < 8 g 
per deciliter)measured by chemical analyzer, history 
of in vitro fertilization and history of anti-
phospholipid syndrome or systemic lupus 
Erythematosus were excluded.Placenta previa was 
determined by ultrasonography before 24 week 
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gestation and defined as placental anchorage within 3 
cm of internal os. One hundred and eighty seven  
pregnant women with placenta previa and 187 
pregnant women without placenta previa according to 
selection criterion were enrolled.  Ultrasonography 
examination was performed on all patients to ascertain 
the attachment of placenta on uterine wall. All patients 
were followed every fourth week till 38th weeks. Pre-
eclampsia was labelled if mean of three readings of 
blood pressure was more than 139/89 in a pregnant 
woman with history of normal blood pressure before 
pregnancy and proteinuria on urine laboratory 
examination. Risk ratio was calculated to determine 
the association between pre-eclampsia and placenta 
Previa. p value <0.05 was considered significant. 
 
Results 
The mean age of patients was 27.23 ± 3.633 ranged 
from 21 to 43 years of age. There were 144 patients 
(38.5%) <25 years of age whereas 230 patients (61.5%) 
were more than 25 years in age (Table 1). About 171 
patients (45.7%) were primipara and 203 patients 
(54.3%) were multipara. Out of 374 patients only 8 
patients (2.1%) were having pre-eclampsia. The 
frequency of pre-eclampsia was significantly higher 
among case group as compared to control group 
(p=0.004) (Table 2). Relative risk came out 1.045 (95% 
confidence level; 1.014 to 1.077)(Table 2) 
Table 1: Baseline characteristics of patients 
Age 27.23±3.63 
Age<25years 144(38.5%) 
Age≥25years 230(61.5%) 
Primiparity 171(45.7%) 
Multiparity 203(54.3%) 
Table 2: Association of preeclampsia  
and placenta previa 
 Preeclampsia Total 
Yes No 
Placenta 
previa 
Yes 8(100%) 179(48.9%) 187 
No 0 187(51.1%) 187 
Total 8 366 374 
Relative Risk = 1.045 (95%CI;1.014, 1.077) 
Discussion 
Iimportant health problems among adolescents in the 
developing countries are increased incidence of 
preterm labour and delivery, hypertensive disease, 
anaemia, more severe forms of malaria, obstructed 
labour, poor maternal nutrition and poor 
breastfeeding, low birth weight and increased neonatal 
mortality and morbidity.13-15PIH has its onset from 20 
weeks of gestation and ranges from hypertension 
alone (gestational hypertension) through proteinuria 
and multi-organ dysfunction (pre-eclampsia) to 
seizures (eclampsia).3Pre-eclampsia may be 
superimposed on pre-existing chronic hypertension. 
Although pre-eclampsia represents the severe end of 
the spectrum, women with any form of pregnancy 
hypertension are at increased risk of adverse 
outcomes.5 Awareness of risk factors of pre-eclampsia 
can help to monitor patients, ensure earlier diagnosis 
and predict which patients are more likely to develop 
pre-eclampsia.16 Placenta praevia is an obstetric 
complication in which the placenta is inserted partially 
or wholly in the lower uterine segment. It is a leading 
cause of antepartum haemorrhage (vaginal 
bleeding).18 
Caesarean delivery is more likely in women with 
preeclampsia. It is to be remembered that delivery is 
the long-term cure, but most women get worse after 
delivery and most maternal deaths occur 
postpartum.19, 20Recently, it has been shown that 
placenta previa is associated with low frequencies of 
pre-eclampsia and low maternal blood pressure.21 
However, there is scant literature on the association 
between placenta previa and pre-eclampsia. While 
some studies reported the protective effects, other 
studies did show any associations, slightly increase in 
the incidence and significantly elevated incidence pre-
eclampsia in placenta previa.11, 22Maternal risks with 
placenta previa include life threatening hemorrhage, 
anesthetic and surgical complications due to 
emergency cesarean delivery with sub optimal 
preparation for surgery. Postpartum hemorrhage, 
cesarean hysterectomy, postpartum sepsis, air 
embolism and abnormal degree of placental adherence 
can often occur.23, 24 
In  present study cohort, out of 374 patients only 8 
patients (2.1%)developed pre-eclampsia. When we 
cross tabulated group with preeclampsia the results 
were significant (p value=0.004). All of the patients of 
pre-eclampsia were in category of no placenta 
previa.Relative risk came out 1.045 ranging from 1.014 
to 1.077 at 95%Confidence interval. So we may reject 
the null hypothesis and may conclude that there is an 
association between placenta previa and preeclampsia 
in pregnant women. It also implies that placenta 
previa has a protective role as concerned with 
pregnancy induced hypertension. There should be a 
focus on mechanisms involving the placement and 
anchorage of placenta during early weeks of gestation. 
Results of present study  matches with previous 
studies. It was reported that placenta previa was a 
significant protective factor of pre-eclampsia(ORD 0.3, 
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95% CI: 0.1–0.7) showing negative association.9 In 
another Japanese study, Pre-eclampsia was observed 
in 0 and 4.1% of women with and without placenta 
previa, respectively (p = 0.004).11 About 144 patients 
(38.5%) in our study population were < 25years of age 
whereas 230 patients (61.5%) were > 25 years in age. It 
implies that there is still room to control or delay age 
of conception in our population by effective techniques 
of population control. 171 patients (45.7%) were 
primipara and 203 patients (54.3%)were multipara. In 
a Sudani Study, there were 3.2% women with pre-
eclampsia out of 54,339 deliveries. The placenta previa 
occurred in 0% and 3.3%, p < 0.001 in pre-eclamptic 
and control women, respectively, thus it became a 
protective factor in this case.22 
The results from one study clearly show a decreased 
frequency of pregnancy-induced hypertension among 
those pregnancies with placenta previa. It was noticed 
that the pathophysiologic mechanisms for this finding 
may be due to altered placental perfusion seen among 
women diagnosed with placenta previa.25 On age 
stratification, after cross tabulation between pre-
eclampsia and placenta previa, 2 pre-eclampsia 
patients were more than 25 years in age whereas 6 
were having age less than 25 years but results were 
non-significant for both age groups (p=0.112 &0.037). 
These results imply that there is no role of advancing 
age on association between placenta previa and pre-
eclampsia in pregnant women. When we performed 
parity stratification after cross tabulation between pre-
eclampsia and placenta previa, 5 patients of pre-
eclampsia were in group multipara and 3 were in 
group primipara. Results for both groups were non-
significant (p=0.059 & 0.121). These result suggest that 
there is no role of parity on association between 
placenta previa and pre-eclampsia in pregnant 
women. 
Conclusion 
Frequency of developing the pre-eclampsia is 
significantly different in groups with and without 
placenta previa (0% vs. 4.1%) (p value < 0.05). Relative 
risk came out 1.045ranging from 1.014 to 1.077 at 95% 
Confidence interval.  
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